Zinc finger (ZNF) transcription factors interact with DNA through zinc finger motifs and play important roles in a variety of cellular functions including cell growth, proliferation, development, apoptosis, and intracellular signal transduction. One-third of ZNF proteins in metazoans contain a highly conserved N-terminal motif known as the Krüppel-associated box (KRAB) domain, which acts as a potent, DNA-binding dependent transcriptional repression module. Analysis of RNA-Seq data generated from a bovine oocyte cDNA library identified a novel transcript, which encodes a KRAB-containing ZNF transcription factor (named ZNFO). Characterization of ZNFO mRNA expression revealed that it is exclusively expressed in bovine oocytes and early embryos. A GFP reporter assay demonstrated that ZNFO protein localizes specifically to the nucleus, supporting its role in transcriptional regulation. To test the role of ZNFO in early embryonic development, zygotes were generated by in vitro maturation and fertilization of oocytes, and injected with small interfering RNA (siRNA) designed to knockdown ZNFO. Cleavage rates were not affected by ZNFO siRNA injection. However, embryonic development to 8-to 16-cell stage and blastocyst stage was significantly reduced relative to the uninjected and negative control siRNA-injected embryos. Further, interaction of ZNFO with the highly conserved co-factor, KRAB-associated protein-1 (KAP1), was demonstrated, and evidence supporting transcriptional repression by ZNFO was demonstrated using a GAL4-luciferase reporter system. Results of described studies demonstrate that ZNFO is a maternally-derived oocyte-specific nuclear factor required for early embryonic development in cattle, presumably functioning by repressing transcription.
Introduction
Early embryonic development is one of the most critical periods in mammalian development and comprises several important transitions including replacement of maternal RNAs with zygotic RNAs, compaction, the first lineage differentiation into the inner cell mass and trophectoderm and, finally, implantation. Various physiological processes and biosynthetic changes regarding genomic activity take place during this early time. Among these events is the first important developmental transition that occurs following fertilization at which time the embryo switches from using transcripts derived from the maternal genome to those synthesized by the zygote as the result of embryonic genome activation (EGA) (Stitzel and Seydoux, 2007) . Mammalian oocytes accumulate a vast collection of mRNA and proteins throughout oogenesis that mediate subsequent embryonic development. During oocyte meiotic maturation and the early stages of embryonic development the transcriptional machinery for this collection of molecules is silent until EGA initiates transcriptional activity within the embryonic nucleus. The onset of EGA is a species-specific event that takes place during the first few cell cycles post-fertilization; around the 8-to 16-cell stage in bovine embryos (Memili and First, 1999; Memili and First, 2000) , several cycles later than observed for the mouse (2-cell stage) or human (4-to 8-cell stage) (Telford et al., 1990; Latham and Schultz, 2001) . Therefore, any developmental events required for early embryogenesis (i.e. meiotic maturation, fertilization, initial cleavage divisions, and programming of EGA) prior to the onset of EGA are regulated by the translation of pre-existing maternal transcripts .
Zinc finger (ZNF) genes compose one of the largest protein superfamilies in eukaryotic organisms and uphold an essential role in Mechanisms of Development 144 (2017) [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] transcriptional regulation. In particular, the Cys2His2 (C2H2) class of ZNFs dominate approximately 53% (~700) of the transcription factor repertoire of the mammalian genome (Vaquerizas et al., 2009 ). Structurally, C2H2 ZNFs are named for the zinc finger motifs, each comprised of 28-30 amino acids, and each stabilized by a zinc ion that coordinates four highly conserved residues, two cysteines and two histidines (Lee et al., 1989) . The carboxy-terminal portion of C2H2 ZNF proteins contain from 1 to N 30 individual zinc finger motifs arranged in a cluster of tandem repeats. Each individual zinc finger motif is defined by the presence of the consensus sequence Φ-X-Cys-X (2-4) -Cys-X 3 -Φ-X 5 -Φ-X 2 -His-X (3-4) -His, where X represents any amino acid and Φ represents a hydrophobic residue (Klug and Schwabe, 1995) . Transcriptional regulation occurs through sequence-specific DNA binding of these motifs to promoter regions of target genes (Lupo et al., 2013) . Although each zinc finger domain is structurally similar, variations of key amino acid residues at particular sites, as well as zinc finger number, create chemical distinctiveness allowing for a great number of possibilities for DNA recognition (Pavletich and Pabo, 1991) and, hence, the variety and presence of ZNFs in nearly all aspects of biological processes (Vaquerizas et al., 2009; Klug and Schwabe, 1995; Urrutia, 2003; Emerson and Thomas, 2009) .
One third of the various conserved domains that contribute to C2H2-ZNF protein function contain the Krüppel-Associated Box (KRAB) domain (Urrutia, 2003) , making KRAB-ZNFs the single largest group of transcriptional repressors in the genomes of higher organisms. The KRAB domain is known as a potent transcriptional repression module responsible for DNA binding-dependent gene silencing activity and is located at the amino-terminal end of most C2H2 ZNF proteins (Margolin et al., 1994; Witzgall et al., 1994) . When tethered to DNA via its zinc finger motifs, the KRAB domain of KRAB-ZNF proteins recruits and interacts with the corepressor protein KRAB-associated protein 1 (KAP1) (Friedman et al., 1996; Moosmann et al., 1996) , which is an absolute requirement for KRAB-containing zinc finger proteins to bind and mediate transcriptional repression. Upon binding to DNA, KAP1 functions as a scaffold to form a multi-molecular complex that induces transcriptional silencing by condensing chromatin. As a powerful transcriptional repressor, most members of the KRAB-ZNF family have diverse functional roles in nearly all tissues and a variety of cellular functions, including cell proliferation and differentiation, metabolism, apoptosis, neoplastic transformation, cell cycle regulation, and regulating embryonic development (Lupo et al., 2013; Urrutia, 2003) .
In an effort to characterize the bovine oocyte transcriptome in search of oocyte-specific factors essential for the regulation of folliculogenesis and early embryonic development in cattle, a bovine oocyte cDNA library was previously constructed. Analysis of RNA-Seq data from this library identified a novel transcript that matches an uncharacterized KRAB-containing zinc finger gene (named ZNFO) which is explicitly expressed in the bovine oocyte. We hypothesized that this novel KRAB-containing zinc finger protein has a distinct and essential role in the development of the early bovine embryos. Herein, we report the identification and cloning of cDNA encoding ZNFO, the temporal expression of ZNFO mRNA during oocyte maturation and early embryonic development, and evidence supporting a critical role for ZNFO in early embryogenesis in cattle. We also show that ZNFO interacts with the highly conserved co-factor, KAP1, and functions as a transcriptional repressor.
Materials and methods

Tissue collection
Bovine tissue samples, including adult lung, spleen, stomach, brain, muscle, kidney, liver, heart, intestine, ovary, adult testis, fetal testis, and fetal ovaries were collected from a local slaughterhouse. Age of fetuses from which fetal ovaries were collected was estimated by measuring crown-rump length (Richardson et al., 1990) . Granulosa and theca cells were isolated from antral follicles as described previously (Murdoch et al., 1981) . All samples were frozen in liquid nitrogen following collection and stored at −80°C until use.
RNA isolation, cDNA synthesis, and RT-PCR analysis
Total RNA was extracted using Tri-reagent (Ambion, Inc., Austin, TX) according to the manufacturer's instructions. Isolated total RNA was treated with TURBO™ DNase I (Ambion) before cDNA synthesis. Approximately 2 μg of DNase-treated total RNA was used for first strand cDNA synthesis in a 20 μl reaction including Oligo (dT) 18 primer and SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA). Concentrations of isolated RNA were determined by measuring absorbance at 260 nm. Purity of RNA was determined by calculating the ratio of absorbance at 260 nm and 280 nm, and integrity of RNA was determined by agarose gel electrophoresis. The cDNA was used as a template for PCR amplification of ZNFO mRNA fragments using gene-specific primers (Supplemental Table S1 ). The RT-PCR was performed by denaturation at 95°C for 3 min followed by 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 90 s and final extension at 72°C for 10 min. The amplified products were separated through a 1% agarose gel containing RGB. Amplification of cDNA for bovine ribosomal protein L19 (RPL19) was used as a positive control for RNA quality and RT.
Plasmid construction
For preparation of glutathione S-transferase (GST) fusion recombinant protein, the open reading frame (ORF) of ZNFO cDNA was amplified and cloned into pGEX-4T1 (GE Healthcare, Salt Lake City, UT) using primers containing SmaI and XhoI sites (pGEX-4T1-ZNFO). The KAP1 ORF was amplified and cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) using a forward primer containing a Kozak sequence and HindIII site and a reverse primer containing a FLAG-tag sequence and BamHI site (pcDNA3.1-KAP1-FLAG). The ZNFO expression construct used in the luciferase reporter assay was generated by cloning the PCR-amplified ZNFO ORF in frame with the GAL4 DNA-binding domain (GAL4DBD) sequence into pBIND vector (Promega, Madison, WI) using SalI and KpnI restriction sites (pBIND-ZNFO). For expression of green fluorescent protein (GFP) fused to ZNFO, the ZNFO ORF sequence was amplified by PCR from the pGEX-4T1-ZNFO plasmid and inserted into pcDNA3-EGFP expression vector (Addgene, Cambridge, MA) (pcDNA3-ZNFO-EGFP). The mutant construct encoding ZNFO-EGFP with the predicted NLS (RHRK) changed to RHAA was generated by cloning the mutant ZNFO ORF (produced by two-step PCR using primers designed to introduce the desired mutations) into pcDNA3-EGFP vector (pcDNA3-ZNFO-RHAA-pEGFP). Deletion constructs expressing ZNFO-EGFP proteins lacking various zinc fingers were generated by PCR amplification of ZNFO fragments using the same gene-specific forward primer in combination with different reverse primers that target different sites in the zinc finger region followed by cloning into pcDNA3-EGFP expression vector. All clones were confirmed by sequencing. All primers used for plasmid construction are listed in Supplemental Table S1 .
Quantitative real-time PCR (RT-qPCR)
Oocyte and embryo samples analyzed for mRNA expression included germinal vesicle (GV) and metaphase II (MII) stage oocytes (n = 4 pools of 10 oocytes), and pronuclear, two-cell, four-cell, eight-cell, 16-cell, morula and blastocyst stage embryos (n = 4 pools of 10 embryos/stage) generated by in vitro fertilization of abattoir-derived oocytes as previously described (Bettegowda et al., 2006) . Quantitative realtime PCR set-up and standardization conditions were carried out as previously described (Wang et al., 2013) . Before RNA extraction, each sample was spiked with 250 fg of GFP synthetic RNA (polyadenylated) as an exogenous control. The quantity of ZNFO mRNA or GFP RNA in each sample was determined using respective standard curves. The quantity of ZNFO mRNA was normalized relative to the quantity of GFP RNA measured in each sample, and differences in normalized data across developmental stages were determined by one-way ANOVA using the statistical analysis package, R. Individual mean comparisons were performed using Fisher least significant difference (LSD) method. Differences of P b 0.05 were considered significant.
Generation of anti-ZNFO antibody and western blot analysis
The ZNFO antibody was prepared commercially by GenScript Corporation (Piscataway, NJ). Polyclonal antiserum against ZNFO was raised by immunizing rabbits with a 15-amino acid synthetic peptide (KRNQGRESNREKPIC) of the predicted amino acid sequence of ZNFO. Antibody was purified by affinity chromatography on columns containing peptide conjugated to affinity resin.
Protein lysate samples were separated on a 4-20% gradient ready gel (Bio-Rad, Hercules, CA), and electrophoresis was run in 1× Tris/Glycine/ SDS running buffer for 2 h. Proteins were transferred onto a Immun-Blot PVDF membrane (Bio-Rad) in 1 × transfer buffer (Tris/Glycine/SDS/ methanol) for 1 h. Following transfer and blocking in 5% nonfat dry milk in PBS containing 0.1% Tween-20 (PBST) for 2 h, the membrane was incubated in 1 μg/mL ZNFO primary antibody solution in blocking buffer overnight at 4°C. After three washes with PBST, immunoreactive proteins were visualized by using a chemiluminescent horseradish peroxidase detection system (Genotech, St. Louis, MO).
GST pull-down assay
The pGEX-4T1-ZNFO construct or pGEX-4T1 vector plasmid (control) was transformed into Rosetta (DE3)pLysS cells (Novagen, Madison, WI) for expression of GST-ZNFO or GST. Bacterial cultures were induced with 2.5 mM isopropyl β-D-thiogalactopyranoside at 28°C for 8 h. Bacterial pellets were collected by centrifugation and lysed in equilibration/wash buffer (125 mM Tris and 150 mM sodium chloride, pH 8.0) by sonication. The clear lysate was incubated and passed through an immobilized glutathione column (Pierce). After washing 3 times with equilibration/wash buffer, the recombinant protein was eluted by the addition of 20 mM glutathione to the buffer. The eluted protein was concentrated using Microcon centrifugal filter devices (Millipore, Bedford, MA). Equal amount of GST or GST-ZNFO protein (2 μg) was immobilized on 100 μL of glutathione beads (Pierce) in 0.3 mL of equilibration/wash buffer. After incubation for 1 h at 4°C, beads were incubated with lysate of cells expressing KAP1-FLAG protein overnight at 4°C. The beads were washed thoroughly, then boiled in Laemmli buffer (containing β-mercaptoethanol) and resolved by SDS-PAGE, followed by Western blot analysis using anti-FLAG primary antibody and infrared fluorescent secondary antibody and visualized on an Odyssey system (Li-COR, Lincoln, NE).
Cell culture and EGFP reporter assay
HEK293 cells were cultured in DMEM supplemented with 10% (v/v) of fetal bovine serum (FBS) in a humidified 5% (v/v) CO 2 incubator at 37°C. The day before transfection, cells were seeded on coverslips in a 6-well plate. Transfection of various ZNFO-EGFP expression constructs was performed with X-tremeGENE 9 (Roche, Indianapolis, IN) at optimized ratios of 3:1 (μL of transfection reagent: μg of plasmid DNA). Twenty-four h after transfection, cells were washed with PBS and fixed with methanol at room temperature for 5 min. Seeded coverslips were placed on slides and sealed with ProLong® Gold antifade reagent with DAPI (Life Technologies, Carlsbad, CA). Fluorescent images were taken with a Zeiss M1 microscope using AxioVision software version 4.8.2.
Luciferase reporter assay
HEK293 cells were grown to 70% confluency in 6-well plates and cotransfected with 0.5 μg of pBIND expression plasmids (either pBIND-GAL4-ZNFO or pBIND empty vector) and 300 ng of luciferase reporter vector (pG5luc) using X-tremeGENE 9 (Roche). After 48 h, cells were split into a 96 well plate and the reactions were carried out using the Dual Glo Luciferase Assay system (Promega) according to the manufacturer's instructions. Relative luciferase activity was calculated as firefly luciferase activity divided by Renilla luciferase activity. Luminescence was measured using a Phoenix GENios Microplate Reader. All experiments were repeated in triplicate. Differences were determined by Student's t-test, or by Tukey-Kramer for the dose-response experiment, with P b 0.05.
RNA interference (RNAi) experiments
Knockdown of endogenous ZNFO in bovine embryos was performed via microinjection of ZNFO small interfering RNA (siRNA). RNAi experiments were conducted according to previously published procedures (Tripurani et al., 2011; Tejomurtula et al., 2009; Lee et al., 2009; with modifications noted herein. The custom dicer-substrate siRNA (DsiRNA) design tool (Integrated DNA Technologies, Coralville, IA) was used to design three distinct siRNA species (Supplemental Table S1 ) targeting the ORF of bovine ZNFO mRNA. The siRNA species were interrogated by BLAST (http://blast.ncbi.nlm.nih.gov/Blast. cgi) search against the bovine transcriptome and genomic database to rule out homology to any bovine sequences. The ZNFO siRNA species were generated commercially (Integrated DNA Technologies, Coralville, IA). Procedures for in vitro maturation of oocytes (obtained from abattoir-derived ovaries), in vitro fertilization to generate zygotes for microinjection, and for subsequent embryo culture were conducted basically as described elsewhere (Bettegowda et al., 2006) . Presumptive zygotes collected at 16-18 h post insemination (hpi) were used in all microinjection experiments. Presumptive zygotes were microinjected with approximately 20 pL of ZNFO siRNA (25 μM). Uninjected embryos and embryos injected with a negative control siRNA (universal control no. 1; Ambion) were used as control groups (n = 3 pools of 20 embryos per treatment). Efficacy of ZNFO siRNA in reducing ZNFO mRNA in 4-cell embryos and ZNFO protein in 8-cell embryos was determined by RT-qPCR and Western blot analysis, respectively. The development of the uninjected or injected embryos (with ZNFO siRNA or negative control siRNA) was evaluated by recording the proportion of embryos that cleaved (48 h after insemination), reached 8-to 16-cell stage (72 h after insemination) and blastocyst stage (7 d after insemination). Each group contained 25-30 embryos per treatment (n = 3 replicates). Percent data were transformed to ArcSine. Differences in treatment means were compared using one-way ANOVA. Differences between % 8-16 cell and % blastocyst were compared using Tukey-Kramer. Comparison of % blastocyst relative to % 8-16 cell were expressed as proportions of % control injected siRNA. Data are expressed as mean ± SEM from three replicates (n = 25-30 zygotes per treatment per replicate). Values with different letters across treatments indicate significant differences (P b 0.05).
Results
Cloning and characterization of ZNFO
Analysis of deep sequencing data from a bovine oocyte cDNA library identified an abundant transcript that matches an uncharacterized gene (LOC100141212) in the NCBI database. Based on this predicted sequence, primers were designed (Supplemental Table S1 ) to amplify the 5′ untranslated region (UTR) and the coding sequence through the putative translation stop codon. The 3′ end of the cDNA sequence was obtained by 3′ rapid amplification of cDNA ends (RACE). The amplified cDNA fragments were cloned, sequenced, and assembled to create the complete cDNA sequence (named ZNFO), which has been deposited in the GenBank database with the accession number: KJ710495.1 (Supplemental Fig. S1A ).
The ZNFO cDNA is 3595 bp in length, which contains an ORF of 2145 bp encoding a protein of 714 amino acids. A search of the Pfam protein database (Punta et al., 2012) in combination with visual inspection of the protein sequence revealed that ZNFO protein contains a conserved Krüppel-associated box (KRAB) domain at the N-terminus and nine zinc finger motifs at the C-terminus (Fig. 1A and B) . The KRAB domain consists of 41 amino acid residues that match the minimal repression module of the conserved KRAB-A box (Fig. 1C) , which is necessary for transcriptional regulation (Margolin et al., 1994; Witzgall et al., 1994; Vissing et al., 1995) . Each zinc finger motif fits the consensus sequence Φ-X-Cys-X (2-4) -Cys-X 3 -Φ-X 5 -Φ-X 2 -His-X (3-4) -His definitive of C2H2 ZNFs (Klug and Schwabe, 1995) , and the remaining seven amino acids in between each finger contain the five canonical linker residues (Wolfe et al., 2000; Klug, 2010) . Using the SUMOsp 2.0 program (Zhao et al., 2014) , the protein was predicted to contain two putative sumoylation sites (Lysines 13 and 260), indicating that the protein might be sumoylated.
BLAST search of the assembled bovine genome sequence in the NCBI database using the ZNFO cDNA sequence identified an annotated bovine chromosome 18 genomic contig sequence (NW_003081470) containing the ZNFO gene which spans over 11.9 kb. Alignment of the cDNA sequence to the genomic sequence using the Splign program (Kapustin et al., 2008) revealed that the ZNFO gene contains 4 exons separated by 3 introns (Supplemental Fig. S1B ), and all splice sites are in agreement with consensus sequences (GT-AG rule). No orthologs of this gene were found in other mammalian genomes through extensive NCBI database search, which suggests that ZNFO is a species-specific gene. Analysis of the 5'flanking sequence of the ZNFO gene using TESS program (http://www.cbil.upenn.edu/tess) identified a number of putative transcription factor binding sites, such as RAR, ERα, AP-1 and OCT4 (Supplemental Fig. S2 ). In addition, a putative E-box was identified by visual inspection, an element known to be necessary for oocyte-specific gene expression (Yan et al., 2006) . The transcription start site (TSS) was predicted using promoter prediction algorithms Tfsearch and Softberry TSSW. Twenty CpG sites from~1600 bp flanking the predicted TSS region were identified (Supplemental Fig. S2 ). The 3′UTR was found to contain two nuclear poly(A) signals (AAUAAA) and three cytoplasmic polyadenylation elements (U 5 A 1-2 U), which are required for translational activation of maternally derived mRNAs .
Analysis of ZNFO mRNA and protein expression
RT-PCR analysis revealed that ZNFO mRNA is undetectable in all somatic tissues analyzed, as well as the adult and fetal testis samples, but is specifically expressed in the fetal ovary ( Fig. 2A) . Further RT-PCR analysis showed that ZNFO mRNA is not expressed in granulosa and theca cells (Fig. 2B) , suggesting that ZNFO expression in the ovary is oocytespecific. Analysis of ZNFO mRNA expression in fetal ovaries of different developmental stages during gestation revealed that ZNFO mRNA can be detected in fetal ovaries as early as day 90 of gestation ( Fig. 2C) , a period when primordial follicles are emerging in cattle (Yang and Fortune, 2008) . The expression of ZNFO mRNA is detectable in fetal ovaries through day 250 of fetal development, suggesting a possible role of this gene in supporting development of primary and secondary follicles which are formed around day 140 and 210 of gestation, respectively (Yang and Fortune, 2008) . These results indicate ZNFO is likely a maternal transcript as it is abundantly present in oocytes and early embryos prior to EGA. The temporal expression of bovine ZNFO mRNA during oocyte maturation (GV-and MII-stage) and early embryonic development (pronuclear, 2-cell, 4-cell, 8-cell, 16-cell, morula, and blastocyst stage) was examined by quantitative real-time PCR (RT-qPCR). The ZNFO transcript is highly abundant in GV-and MII-stage oocytes, and is also highly expressed in pronuclear stage embryos through 8-cell stage embryos ( Fig. 3 ; P b 0.05). By the time of the 16-cell stage, ZNFO mRNA markedly declines and is barely detectable in embryos collected at morula and blastocyst stages (Fig. 3A) . The expression pattern of ZNFO mRNA during oocyte maturation and early embryogenesis is similar to many other known bovine maternal-effects genes necessary for early embryonic development (Tripurani et al., 2011; Tejomurtula et al., 2009; suggesting that ZNFO is of maternal origin.
GV and MII stage oocytes were examined for the presence of ZNFO protein by Western blot analysis using anti-ZNFO antibody. The immunoreactive ZNFO protein was detected in both GV and MII stage oocytes (Supplemental Fig. S3A ). The protein is approximately 81 kD, which is close to the predicted ZNFO protein size. Further analysis showed that no specific ZNFO protein was detected in either cumulus cells or a uterus sample (Supplemental Fig. S3B ).
Subcellular localization of ZNFO
The subcellular localization of ZNFO was examined by a GFP reporter assay. Fluorescent imaging of HEK293 cells overexpressing ZNFO-EGFP (ZNFO-wt) indicates that ZNFO is primarily localized in the nucleus (Fig. 4A, panel b) , suggesting that ZNFO functions as a nuclear protein.
The mutant ZNFO (ZNFO-RHAA) with the predicted NLS (RHRK) changed to RHAA also showed diffuse nucleoplasmic staining in the transfected cells (Fig. 4A, panel c) . In contrast, GFP protein showed clear cytoplasmic expression in cells transfected with the empty GFP Fig. 2 . Analysis of ZNFO mRNA expression by RT-PCR. A) Expression of ZNFO mRNA is restricted to oocyte-rich fetal ovaries. B) ZNFO mRNA is expressed only in oocyte-rich fetal ovaries but not in surrounding granulosal cells or thecal cells. C) ZNFO mRNA in fetal ovaries from gestational day 90 to 250. ZNFO mRNA is detected in fetal ovaries throughout gestation. Bovine RPL19 was used as an internal control. Fig. 3 . Expression of ZNFO mRNA during oocyte maturation and early embryonic development. Relative abundance of ZNFO mRNA was determined by RT-qPCR in bovine oocytes and in vitro produced early embryos including GV and MII stage oocytes, pronuclear, 2-cell, 4-cell, 8-cell, 16-cell, morula, and blastocyst stage embryos. ZNFO transcript levels were normalized relative to abundance of GFP RNA (exogenous control) and are shown as mean ± SEM (n = 4 pools of 10 oocytes or embryos/stage). Different letters indicate statistical difference (P b 0.05).
vector (Fig. 4A, panel a) . Therefore, the predicted NLS sequence does not appear to be responsible for nuclear localization of ZNFO protein.
Because some zinc finger proteins can possess NLS sequences in the zinc fingers (Wang et al., 2014; Ito et al., 2009; Tan et al., 2013) , additional experiments were conducted to determine if the real NLS is located in any of the zinc fingers of ZNFO. Mutant constructs expressing ZNFO proteins with a series of deletions of different zinc fingers were created (Fig. 4B) . The mutant ZNFO with its nine zinc fingers deleted (ZNFOΔ1-9) showed cytoplasmic localization (Fig. 4C, panel a) , indicating the zinc fingers contain the NLS. The mutant ZNFO proteins with either the last three or six zinc fingers deleted (ZNFOΔ7-9 or ZNFOΔ4-9) displayed nuclear localization (Fig. 4C, panels b and c) , indicating the NLS is likely located in the first three zinc finger motifs. Further analysis showed that the mutant ZNFO possessing only the first zinc finger motif (ZNFOΔ2-9) is cytoplasmic while the mutant with the last seven zinc fingers removed (ZNFOΔ3-9) is located in the nucleus (Fig. 4C, panels  d and e) . This suggests that the real NLS is located in the second zinc finger motif of ZNFO, although the exact NLS sequence has yet to be identified.
Effect of ZNFO knockdown on early embryonic development
To investigate the function of ZNFO in early embryonic development, RNAi experiments were performed to reduce the expression of ZNFO in bovine embryos. Three ZNFO siRNA species were commercially obtained and initial experiments performed to test the efficacy of these siRNAs in reducing ZNFO expression following microinjection into presumptive zygotes after in vitro fertilization. One particular siRNA species (siR5) was able to reduce ZNFO mRNA abundance by~99% (Fig. 5A ) and ZNFO protein to nearly undetectable level in 4-cell embryos (Supplemental Fig. S4) . This siRNA was then used in the subsequent microinjection studies.
The ZNFO siRNA was microinjected into in vitro fertilized oocytes and the cleavage rate of zygotes, and proportion of embryos developing to 8-to 16-cell stage and blastocyst stage were examined. Injection of ZNFO siRNA did not affect the cleavage rate (Fig. 5B ) but reduced the proportion of embryos developing to 8-to 16-cell stage (Fig. 5C ) relative to uninjected and negative control siRNA-injected embryos (P b 0.05). Likewise, ZNFO siRNA injection decreased the proportion of embryos developing to the blastocyst stage compared with the uninjected and negative control siRNA-injected embryos ( Fig. 5D ; P b 0.05). Further, by evaluating the effects of ZNFO siRNA on blastocyst development relative to the effects on 8-to 16-cell development, it is apparent that following the 8-to 16-cell stage the most dramatic effects on embryo survival are observed (Supplemental Fig. S5 ). These results clearly demonstrate an impaired ability of bovine zygotes to reach the blastocyst stage following knockdown of ZNFO, establishing an important functional requirement of ZNFO during bovine early embryogenesis.
Interaction of ZNFO with KAP1
The hypothesis that ZNFO functions as a transcriptional repressor is largely based on the identification of a KRAB domain located at the Nterminal end of ZNFO protein. KRAB-containing ZNF proteins are wellestablished interacting partners of KAP1 protein (Friedman et al., 1996; Moosmann et al., 1996; Kim et al., 1996; Iyengar and Farnham, 2011) . The highly conserved function of KAP1 illustrates an event in which KAP1 recruits several co-factor complexes upon binding KRABcontaining ZNF proteins and subsequently repress transcription by inducing heterochromatin formation (Groner et al., 2010) . Therefore, a GST pull-down assay was performed to determine whether ZNFO interacts with KAP1. ZNFO was fused to the C-terminus of GST and tested for its ability to bind KAP1. The in vitro-binding assay showed that KAP1 has a strong binding affinity for ZNFO but not with the GST protein control or the mutant ZNFO with the KRAB domain removed (Fig. 6) . These results illustrate that ZNFO interacts with KAP1 and the KRAB domain is the required interface for ZNFO and KAP1 interaction.
Transcriptional repressive activity of ZNFO
Based on the fact that ZNFO harbors the highly conserved KRAB domain and interacts with the corepressor KAP-1, it is likely that ZNFO functions as a transcriptional repressor. To test the effect of ZNFO on transcription, a luciferase reporter assay was performed using the firefly luciferase reporter vector, pG5luc (Promega), which contains five GAL4 binding sites upstream of a minimal TATA box (Fig. 7A) . The pG5luc reporter was transiently introduced into HEK293 cells along with the construct (pBIND-ZNFO) expressing ZNFO fused to the GAL4-DNA binding domain (GAL4DBD) or the pBIND vector expressing GAL4DBD only. The luciferase activity is significantly decreased in the cells expressing GAL4DBD-ZNFO compared to the cells transfected with the pBIND vector (GAL4DBD only) (Fig. 7B) , suggesting that ZNFO possesses intrinsic transcriptional repressive activity. However, co-transfection using different amounts of plasmid DNA of the pBIND-ZNFO construct did not exhibit a dose-dependent effect on luciferase activity. (Fig. 7C) .
Discussion
The present studies report the cloning and functional characterization of a novel oocyte-specific gene in cattle. The predicted protein encoded by this novel gene contains a highly conserved KRAB domain and nine tandem zinc finger motifs, and therefore, it is a new member of the KRAB-containing zinc finger family. The most striking characteristic of the KRAB-ZNF family of transcription factors is their ability to repress transcription, which probably underlies the many biological processes in which they are implicated (Lupo et al., 2013; Urrutia, 2003) . The results herein indicate that expression of ZNFO is oocytespecific, which, to our knowledge, is the first report of a KRAB-containing ZNF gene found strictly in the oocyte of any species.
The ability of an oocyte to become developmentally competent requires that it gain the capacity to resume meiosis, cleave following fertilization, and resulting embryos develop to the blastocyst stage and implant, and offspring develop to term in good health (Krisher, 2004; Picton et al., 1998; Gilchrist and Thompson, 2007; Sirard et al., 2006) . Oocytes gradually and sequentially acquire competence throughout folliculogenesis by synthesizing and accumulating transcripts and proteins that are necessary for successful follicular development, fertilization and subsequent embryogenesis (Eppig et al., 2002) . The early stages are critical because many oocyte-specific genes are transcribed during the primordial to primary follicle transition and continue to be expressed throughout folliculogenesis. Many of these factors are not only found during follicular development but also prior to that in embryonic gonad formation and germline establishment. By 90 days of gestation, a time when the first primordial follicles develop following germline establishment in cattle (Yang and Fortune, 2008) , ZNFO was detectable. Indeed, several known oocyte-specific transcription factors have been shown to be essential for normal development of germ cells and surrounding somatic cells during mammalian folliculogenesis (Adolfo Palma et al., 2012; Pangas and Rajkovic, 2006; Choi and Rajkovic, 2006) .
Following expression in pre-ovulatory oocytes, ZNFO displayed a continued expression throughout early development of the bovine Fig. 6 . In vitro interaction between ZNFO and KAP1 analyzed by a GST pull-down assay. Cell lysate containing overexpressed FLAG-tagged KAP1 was incubated with immobilized GST-tagged ZNFO with the KRAB domain removed (GST-ZNFOΔK) or GSTtagged wild type ZNFO (GST-ZNFO) or GST protein. The pull-down products were analyzed by Western blot analysis using anti-FLAG antibody.
embryo, until the 16-cell stage when it dramatically decreased. The ability of the bovine embryo to reach the blastocyst stage and ultimately develop into a healthy offspring is a complex and highly regulated process. Maternal transcripts are replaced and are degraded during different stages of embryogenesis by the embryonic genome, which is transcriptionally inactive before maternal-zygotic transition, and is activated at the onset of maternal-to-zygotic transition (Schier, 2007) . Therefore, the transition from maternal to embryonic control of development is characterized by degradation of maternal transcripts and proteins, sensitivity to transcriptional inhibitors (e.g. α-amanitin), and a dramatic increase in transcriptional activity from the embryonic genome (BilodeauGoeseels and Schultz, 1997) . This crucial transition occurs during the first few post-fertilization cell cycles in a species dependent manner. Embryonic genome activation occurs at roughly the 2-cell stage in mice, 4-to 8-cell stage in humans, and 8-to 16-cell stage in cattle (Memili and First, 1999; Memili and First, 2000) . Accumulating experimental evidence, including relatively recent data in cattle (Tripurani et al., 2011; Tejomurtula et al., 2009; , indicates that maternal-effect genes are key regulators of folliculogenesis and subsequent early cleavage events post fertilization. The results presented here show that ZNFO is specifically expressed in oocytes and early embryos prior to-and during the onset of embryonic genome activation, displaying maximum expression from GV to 8-cell stages and then rapidly declining to near non-existence by morula and blastocyst stages. This specific expression pattern is similar to several oocyte-expressed genes that have been reported to be essential for initial stages of embryonic development, and therefore, suggests that ZNFO may be a maternal-effect gene.
Considering the vast diversity of tissue cell-type localization and functional roles of KRAB-containing ZNF proteins, it is quite interesting to find that no other KRAB-ZNF proteins have been identified that is exclusive to the oocyte. In similar light, ZNFO does not seem to have any orthologs. The timing established for major EGA demonstrates an occurrence that is generally later in mono-ovulatory species, such as cattle and primates (including human), as compared with poly-ovulatory species such as the mouse, in which EGA manifests much sooner. Therefore, the maternal-effect genes required to promote initial cleavage divisions and ensure successful early embryonic development in such mono-ovulatory species may be divergent from those required in the poly-ovulatory species. Further, within mono-ovulatory species, a distinct speciesspecific factor may be part of a common and highly conserved functional network. Oocyte-specific factors required for early embryogenesis in bovine species are poorly understood, and understanding the contribution of such factors to maternal-to-embryonic transition during early embryogenesis in cattle is limited.
Results of the present study clearly support a functional role of ZNFO in early embryonic development in a livestock species and demonstrate that ZNFO knockdown dramatically impaired development to the blastocyst stage. Bovine in vitro culture systems demonstrate that a developmental block arises around the 8-cell stage in most embryos, and, thus, EGA is considered to be the most critical event for early developmental viability (Meirelles et al., 2004) . The results further suggest that ZNFO may be required during the early stages of embryonic development before activation of the embryonic genome, because ZNFO siRNA injection significantly reduced the development of embryos at the 8-to 16-cell stages. When the effect of ZNFO on the 8-to −16 cell stage relative to the blastocyst stage was compared, a greater influence on embryo survival was demonstrated for the blastocysts. The requirement of ZNFO during EGA is indeed essential, but the requirement during blastocyst development appears absolute. Fig. 7 . Transcriptional repressive activity of ZNFO analyzed by a GAL4-luciferase reporter assay. A) Schematic representation of the pG5luc reporter vector and expression constructs. The pG5luc reporter vector contains five GAL4-binding sites upstream of the firefly luciferase gene. The ZNFO gene is fused in-frame to the GAL4DBD sequence in pBIND vector. Dark shaded boxes represent zinc finger domains. B) Transcriptional repression by ZNFO. HEK293 cells were transfected with 500 ng of pBIND-ZNFO plasmid or pBIND vector plasmid, together with 500 ng of pG5luc plasmid. C) Dose response of transcriptional repression by ZNFO. HEK293 cells were transfected with 0, 50, 100, or 500 ng of pBIND-ZNFO expression plasmid, each supplemented with pBIND plasmid to 500 ng total, together with 300 ng of the luciferase reporter plasmid. Relative luciferase activity was calculated as firefly luciferase activity divided by Renilla luciferase activity. The data were shown as mean ± SEM, and all experiments were performed in triplicate. Significant differences are noted by * and differing letters, with P b 0.05.
Oocyte maturation includes several morphological changes accompanying the progression of meiosis from prophase I to metaphase II. These changes lead the oocyte to a stage of chromosome condensation and transcriptional silencing, which will last until EGA (Kotani and Yamashita, 2002) . The molecular mechanisms of KRAB-ZNF-mediated transcriptional regulation requires interaction with chromatin-remodeling factors. The universal co-repressor KAP1 acts as a scaffold for chromatin-modifying complexes and chromatin remodeling activities by recruitment to the promoters of target genes and initiating ATP-dependent activities that modify chromatin. KAP1 harbors an N-terminal RBCC region that is responsible for KRAB domain binding (Friedman et al., 1996) , while the central HP1-binding domain and C-terminal tandem PHD-bromodomain (PB) are required for gene silencing. The PB domain recruits factors found in the NuRD complex and SETDB1, which mediate nucleosome remodeling and histone deacetylation, and trimethylation of histone H3 at Lys-9, respectively, to create high affinity genomic binding sites for the KAP1-HP1 complex (Schultz et al., 2002; Schultz et al., 2001) . The KRAB-ZNF-KAP1 complex then induces heterochromatin formation following recognition of local cis-acting sequences (Groner et al., 2010; Lechner et al., 2000) . Studies on the roles of KRAB-containing ZNF transcription factors and interaction with KAP1 show that there are various effects during embryonic developmental processes including maintenance of the imprinting of genes, maturation of bone cells and hematopoiesis, and regulation of convergent extension in mouse embryo (Li et al., 2008; Garcia-Garcia et al., 2008; Zheng and Blobel, 2010) . Although these factors have begun to uncover a few of the complex functional requirements of ZNFs in early embryonic development, they are focused on mouse and human models. In this study, ZNFO demonstrated the ability to physically interact with KAP1, with high affinity. By removal of the N-terminal KRAB domain, it was demonstrated that this region is indeed the interaction interface responsible for interaction with KAP1. ZNFO also consistently demonstrated the ability to repress transcription in the GAL4-reporter system. These results suggest that, in a physiological context, ZNFO is abundantly expressed in bovine oocytes and early embryos as a negative regulator of transcription by binding to the KAP1 co-factor. Further, ZNFO is localized only to the nucleus, supporting the idea that ZNFO is potentially involved in the regulation of zygotic transcriptional activity within the embryonic nucleus around the time of EGA. In an effort to delineate the region responsible for this nuclear localization, the predicted NLS was mutated; however, that particular monopartite region was not responsible. What does seem to be important is the region within the second zinc finger motif. Knowledge of the proper NLS is beneficial because these signal sequences reveal protein interaction groups, and, hence, potential functional activities of ZNFO. These observations, in accordance with generalized theory, suggest a model in which KRAB-ZNF-KAP1-dependent recruitment of histone modifiers for histone methylation and formation of facultative heterochromatin act to achieve gene silencing. By such a mechanism, it is possible that ZNFO, as a transcriptional repressor, regulates fundamental genes required for activation of the embryonic genome.
In summary, the results presented in this study demonstrated that ZNFO is an oocyte-specific KRAB-ZNF transcription factor that plays a key role in ensuring early embryo survival possibly by regulating transcription through its established interaction with the co-repressor KAP1. The downstream target genes regulated by ZNFO remain to be investigated.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.mod.2017.02.003.
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